Ph.D. in Biotechnology, Biochemistry, Life Sciences, Microbiology, Chemistry, or related disciplines Development of inhibitors against FMO 3 and TMA lyases that involved in progression of atherosclerosis.
Support development, optimization, validation and transfer of analytical methods using Mass Spectrometry techniques for pharmaceutical products and materials.
Maps potential of territory bringing in insights from market trends, referral pathway bottlenecks, competitors’ activities and unmet needs from a patient and care-giver perspective.
Green Field Project -Equipment Qualification & Computer System Validation, HVAC, Water System, Compressed Air, Nitrogen system Qualification & Temperature Mapping.
Support compliance documentation activities related to computer systems, including review coordination, evidence collection, document quality checks, and maintenance of controlled documentation.
Roche has established Global Analytics and Technology Center of Excellence (GATE) at Chennai and Hyderabad to drive analytics & technology driven solutions by partnering with Roche affiliates across the globe
In a significant move to strengthen the regulation of advanced biological therapies in India, the Ministry of Health and Family Welfare has notified the Drugs (Eighth Amendment) Rules, 2026, expanding the scope of the Central Licence Approving Authority (CLAA) under the Drugs Rules, 1945. Through this amendment, Cell or Stem Cell Derived Products, Gene Therapeutic Products, and Xenografts have been formally included alongside Recombinant DNA (r-DNA) derived drugs within the CLAA licensing framework.